Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Improving Translational Accuracy02:07

Improving Translational Accuracy

11.7K
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
11.7K
Clinical Trials01:16

Clinical Trials

6.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.9K
Translation01:31

Translation

142.5K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
142.5K
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

13
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
13
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

19
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
19

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

International collaborative experiences in managing pyoderma gangrenosum in patients with inflammatory bowel disease.

Therapeutic advances in gastroenterology·2026
Same author

[Appendectomy as a disease-modifying therapy in ulcerative colitis?]

Zeitschrift fur Gastroenterologie·2026
Same author

Time to rethink washout periods in inflammatory bowel disease clinical trials: an international Delphi consensus.

Journal of Crohn's & colitis·2026
Same author

Early transmural response assessed by intestinal ultrasound predicts long-term clinical remission in patients with IBD: Results from the TRUST BEYOND study.

Inflammatory bowel diseases·2026
Same author

Mirikizumab is associated with rapid and sustained improvements in novel measures of bowel urgency in moderately-to-severely active ulcerative colitis: 28-week results from the LUCENT-URGE trial.

Journal of Crohn's & colitis·2026
Same author

Timing matters: recommendations for outcome assessment in real-world evidence studies of Crohn's disease.

Journal of Crohn's & colitis·2026

Related Experiment Video

Updated: Jul 25, 2025

Clinical-oriented Three-dimensional Gait Analysis Method for Evaluating Gait Disorder
06:54

Clinical-oriented Three-dimensional Gait Analysis Method for Evaluating Gait Disorder

Published on: March 4, 2018

14.2K

Review article: Translating STRIDE-II into clinical reality - Opportunities and challenges.

Axel Dignass1, Stefan Rath2, Thomas Kleindienst2

  • 1Department of Medicine I, Agaplesion Markus Hospital, Frankfurt/Main, Germany.

Alimentary Pharmacology & Therapeutics
|June 29, 2023
PubMed
Summary

The STRIDE-II guidelines offer a treat-to-target approach for inflammatory bowel diseases (IBD). This strategy aims to personalize patient management and improve outcomes by setting ambitious treatment goals like mucosal healing.

Keywords:
Crohn’s disease < disease-basedbiologics (IBD) < topicsinflammatory bowel disease < disease-basedulcerative colitis < disease-based

More Related Videos

Home-Based Monitor for Gait and Activity Analysis
07:24

Home-Based Monitor for Gait and Activity Analysis

Published on: August 8, 2019

6.8K
The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
08:36

The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living

Published on: July 28, 2022

3.8K

Related Experiment Videos

Last Updated: Jul 25, 2025

Clinical-oriented Three-dimensional Gait Analysis Method for Evaluating Gait Disorder
06:54

Clinical-oriented Three-dimensional Gait Analysis Method for Evaluating Gait Disorder

Published on: March 4, 2018

14.2K
Home-Based Monitor for Gait and Activity Analysis
07:24

Home-Based Monitor for Gait and Activity Analysis

Published on: August 8, 2019

6.8K
The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
08:36

The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living

Published on: July 28, 2022

3.8K

Area of Science:

  • Gastroenterology and Hepatology
  • Internal Medicine
  • Clinical Therapeutics

Background:

  • Novel therapies for inflammatory bowel diseases (IBD) necessitate advanced treatment strategies.
  • The 'treat-to-target' approach is gaining traction to enhance patient outcomes in IBD.
  • Personalized management is key for improving both short- and long-term results in IBD patients.

Purpose of the Study:

  • To evaluate the opportunities and challenges of the treat-to-target approach in IBD.
  • To discuss the implications of the STRIDE-II consensus recommendations for clinical practice.

Main Methods:

  • Review of the 2021 update of the 'Selecting Therapeutic Targets in Inflammatory Bowel Disease' (STRIDE-II) consensus.
  • Analysis of 13 evidence- and consensus-based recommendations for treat-to-target strategies.
  • Assessment of the potential implications and limitations for clinical application.

Main Results:

  • The STRIDE-II guidelines offer valuable direction for personalized IBD management.
  • The recommendations reflect scientific advancements and growing evidence supporting ambitious treatment goals.
  • Achieving goals such as mucosal healing is linked to improved patient outcomes.

Conclusions:

  • The STRIDE-II consensus provides a framework for optimizing IBD treatment.
  • Further research is needed to refine 'treat-to-target' strategies.
  • Prospective studies, objective risk stratification, and better response predictors are essential for future efficacy.